Boston Scientific (NYSE: BSX) today announced positive 12-month study results for its Farapulse pulsed field ablation (PFA) ...

Boston Scientific has launched its Farawave NAV ablation catheter and Faraview software after the US Food and Drug ...

Boston Scientific said that while tariffs pose “unfortunate” headwinds—which are poised to add about $200 million to the cost ...

Subjects in the study were monitored using the LUX-Dx insertable cardiac monitor system to detect arrhythmia recurrence.

Boston Scientific has proven itself to be a fierce ... left atrial appendage closure and atrial fibrillation ablation products. The firm has also acquired adjacent technologies that open the ...

Boston Scientific will face more benign competition than previously feared when it comes to pulsed field ablation, according ...

Boston Scientific (BSX) announced positive 12-month primary endpoint results from the second phase of the ADVANTAGE AF clinical trial ...

Abbott is joining the worldwide race to make pulsed field ablation the standard procedure for atrial fibrillation with an approval in Europe for its Volt system. Boston Scientific, Medtronic and ...

The firm pointed to a recent survey of heart specialists, which showed that Boston Scientific’s FARAPULSE system remains the preferred option for a common heart procedure called ablation.